Education
About Us
Working with TipRanks
Follow Us
Strata Skin Sciences Inc (SSKN)
NASDAQ:SSKN
SSKN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.51 - $5.60
Previous CloseN/A
Volume547.00
Average Volume (3M)2.06K
Market Cap
$11.18M
Enterprise Value$19.98M
Total Cash (Recent Filing)$30.04M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.15
Next Earnings
May 20, 2025EPS Estimate
-0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.59
Shares Outstanding4,171,161
10 Day Avg. Volume1,546
30 Day Avg. Volume2,059
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.34
Price to Cash Flow (P/CF)-9.30
P/FCF Ratio0.00
Enterprise Value/Market Cap1.79
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.08
Enterprise Value/Ebitda-10.04
Forecast
1Y Price Target
$10.00Price Target Upside281.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Strata Skin Sciences News
PremiumCompany Announcements
Strata Skin Sciences Reports Positive Earnings with Key Growth Areas
PremiumCompany Announcements
STRATA Skin Sciences Reports Growth Amid Strategic Shifts
PremiumCompany Announcements
Strata Skin Sciences Reports Q4 2024 Financial Results
PremiumCompany Announcements
Strata Skin Sciences Highlights XTRAC® Laser Study Success
---
Bulls Say, Bears Say
Bulls Say
International MarketsInternational markets have gained traction, with expectations for continued momentum as the company re-educates partners on the technology and its benefits.
Turnaround PlanThe company's turnaround plan is showing early signs of success, focusing on direct-to-consumer marketing, cost efficiency, and improving revenue per device.
ValuationShares currently trade at an EV/revenue multiple of 0.5x our 2025 estimate, below the peer average, suggesting potential for valuation growth.
Bears Say
EarningsThe company reported a GAAP loss per share significantly wider than expectations, mostly due to an impairment of goodwill charge.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SSKN FAQ
What was Strata Skin Sciences Inc’s price range in the past 12 months?
Strata Skin Sciences Inc lowest stock price was $2.51 and its highest was $5.60 in the past 12 months.
What is Strata Skin Sciences Inc’s market cap?
Strata Skin Sciences Inc’s market cap is $11.18M.
When is Strata Skin Sciences Inc’s upcoming earnings report date?
Strata Skin Sciences Inc’s upcoming earnings report date is May 20, 2025 which is in 25 days.
How were Strata Skin Sciences Inc’s earnings last quarter?
Strata Skin Sciences Inc released its earnings results on Mar 27, 2025. The company reported -$0.865 earnings per share for the quarter, missing the consensus estimate of -$0.3 by -$0.565.
Is Strata Skin Sciences Inc overvalued?
According to Wall Street analysts Strata Skin Sciences Inc’s price is currently Undervalued.
Does Strata Skin Sciences Inc pay dividends?
Strata Skin Sciences Inc does not currently pay dividends.
What is Strata Skin Sciences Inc’s EPS estimate?
Strata Skin Sciences Inc’s EPS estimate is -0.52.
How many shares outstanding does Strata Skin Sciences Inc have?
Strata Skin Sciences Inc has 4,171,161 shares outstanding.
What happened to Strata Skin Sciences Inc’s price movement after its last earnings report?
Strata Skin Sciences Inc reported an EPS of -$0.865 in its last earnings report, missing expectations of -$0.3. Following the earnings report the stock price went down -0.738%.
Which hedge fund is a major shareholder of Strata Skin Sciences Inc?
Currently, no hedge funds are holding shares in SSKN
---
Company Description
Strata Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
---
SSKN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with significant improvements in average net revenue per device, strong gross margins, and impressive international sales growth. However, challenges remain with the decline in the U.S. XTRAC installed base, flat global net recurring revenue, and increased operating expenses. Overall, the highlights outweigh the lowlights, indicating a positive sentiment.Read More>---
SSKN Stock 12 Month Forecast
Average Price Target
$10.00
▲(281.68% Upside)
Technical Analysis
Best Analysts Covering SSKN
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-17.83%
reiterated a buy rating 26 days ago
Copying Jeffrey Cohen's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -17.83% per trade.
---